Comparison: Constant-rate Infusion Plus Demanding Dosing VS Variable-rate Feedback Infusion Plus Demanding Dosing

Sponsor
Chung-Ang University Hosptial, Chung-Ang University College of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT03102333
Collaborator
(none)
78
1
2
12
6.5

Study Details

Study Description

Brief Summary

In the case of the newlys developed PCA, the infusion rate is increased according to the patient's need for bolus button, so that the pain can be controlled more efficiently.

Condition or Disease Intervention/Treatment Phase
  • Device: Variable-rate Feedback Infusion mode
  • Device: Constant-rate Infusion mode
N/A

Detailed Description

In the case of the existing iv-pca, the analgesic drug was injected into the patient at a constant rate (ex. 1 ml / hr) and additional pain was controlled through the bolus dose (1 ml).

As a result, the analgesic effect was insufficient, or the effect was excessive, causing side effects (nausea, vomiting, sedation, dizziness). Especially In spinal surgery, the degree of pain sharply decreases from day 1 to day 2. Classic iv-pca with constant infusion rate can not reflect this result. But in the case of the newlys developed PCA, the infusion rate is increased according to the patient's need for bolus button, so that the pain can be controlled more efficiently. If the bolus button is not pressed for a certain period of time, it is expected that the injection rate will be reduced and the side effect caused by the analgesic agent will be decreased.

Study Design

Study Type:
Interventional
Actual Enrollment :
78 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Comparison: Constant-rate Infusion Plus Demanding Dosing VS Variable-rate
Actual Study Start Date :
Dec 30, 2016
Actual Primary Completion Date :
Dec 29, 2017
Actual Study Completion Date :
Dec 29, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Constant-rate Infusion

INTERVENTION : Constant-rate Infusion mode : The PCA regimen consisted of fentanyl 20 μg/kg and Ramosetron Hcl 0.3 mg (total volume including saline: 100 ml) and was programmed to deliver 1 ml /h as a background infusion and a bolus of 1.5 ml on-demand, with a 15 min lockout time during a 48 h period

Device: Constant-rate Infusion mode
The PCA regimen consisted of fentanyl 20 μg/kg and Ramosetron Hcl 0.3 mg (total volume including saline: 100 ml) and was programmed to deliver 1 ml /h as a background infusion and a bolus of 1.5 ml on-demand, with a 15 min lockout time during a 48 h period

Active Comparator: Variable-rate Feedback Infusion

INTERVENTION : Variable-rate Feedback Infusion mode :The PCA regimen consisted of fentanyl 20 μg/kg and Ramosetron Hcl 0.3 mg (total volume including saline: 100 ml) and was programmed to deliver 1 ml /h as a background infusion and a bolus of 1.5 ml on-demand, with a 15 min lockout time. It can increment or decrement rate(0.2ml/hr) by press bolus button during a 48 h period

Device: Variable-rate Feedback Infusion mode
The PCA regimen consisted of fentanyl 20 μg/kg and Ramosetron Hcl 0.3 mg (total volume including saline: 100 ml) and was programmed to deliver 1 ml /h as a background infusion and a bolus of 1.5 ml on-demand, with a 15 min lockout time. It can increment or decrement rate(0.2ml/hr) by press bolus button during a 48 h period

Outcome Measures

Primary Outcome Measures

  1. Demanded numbers of bolus button [Change from immediately to 24 hours after operation]

Secondary Outcome Measures

  1. Pain intensity [Change from immediately to 24 hours after operation]

    by Numerical Rating Scale(NRS)

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Spine fusion surgery at Chung-Ang University Hospital with IV- PCA under general anesthesia
Exclusion Criteria:
  • Unrecorded type of anesthetic agent

  • Denial to the study

  • Brain disorder

  • Cardiopulmonary disease

  • Psychiatric disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chung-Ang University Hospital Seoul Korea, Republic of 156-755

Sponsors and Collaborators

  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chongwha Baek, Professor, Chung-Ang University Hosptial, Chung-Ang University College of Medicine
ClinicalTrials.gov Identifier:
NCT03102333
Other Study ID Numbers:
  • CAUH-SP1
First Posted:
Apr 5, 2017
Last Update Posted:
Jul 18, 2018
Last Verified:
Jul 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2018